Evidence map›Paper›PMID 26770271›Full record

ReviewTherapeutic advances in gastroenterology2016

Nausea: a review of pathophysiology and therapeutics.

Prashant Singh, Sonia S Yoon, Braden Kuo

2 registry-linked trialsAbstract readReview
In one paragraph

Review in Therapeutic advances in gastroenterology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 70 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06382012 phase2 / phase3recruitingnot on this mapstarted 2024, after this paper: background citation

Antiemetic Fosaprepitant To Remedy Nausea and Vomiting

TypeinterventionalSponsorMontefiore Medical CenterRan2024 to 2027Enrolled200ConditionsNausea and Vomiting, Nausea, VomitingArmsFosaprepitant 150 mg, Ondansetron 4 mg
NCT06740812 phase4not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Broadening Antiemetics Research by Comparing the Effectiveness of Fosaprepitant and Metoclopramide: A Randomized Control Trial

TypeinterventionalSponsorMontefiore Medical CenterRan2026 to 2027Enrolled212ConditionsNausea and Vomiting, Nausea, VomitingArmsFosaprepitant for Injection, Metoclopramide Injection
3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Effects of exercise on life satisfaction of people diagnosed with cancer: a systematic review and meta-analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Pooled it
  4. Pooled it
  5. SEOM clinical guideline emesis (2021).Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2022
    Guideline
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Refractory nausea in an 86-year-old patient after surgery.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2026
    Article
  14. Review
  15. Article
  16. Real-world incidence of nausea and vomiting induced by antineoplastic agents: insights and future directions from the Japanese adverse drug event report database.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  17. Article
  18. Article
  19. Observational
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Prashant SinghDivision of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Sonia S YoonDivision of Gastroenterology, Weill Cornell Medical College, New York, NY, USA.
Braden KuoMassachusetts General Hospital - GI Unit, 55 Fruit Street, Blake 4, Boston, MA 02114, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The sensation of nausea is a common occurrence with diverse causes and a significant disease burden. Nausea is considered to function as a protective mechanism, warning the organism to avoid potential toxic ingestion. Less adaptive circumstances are also associated with nausea, including post-operative nausea, chemotherapy-induced nausea, and motion sickness. A common definition of nausea identifies the symptom as a precursor to the act of vomiting. The interaction, though present, does not appear to be a simple relationship. Nausea is unfortunately the 'neglected symptom', with current accepted therapy generally directed at improving gastrointestinal motility or acting to relieve emesis. Improved understanding of the pathophysiological basis of nausea has important implications for exploiting novel mechanisms or developing novel therapies for nausea relief.

Indexed as

autonomic nervous systemcentral nervous systemdiagnosticsnauseaneuroendocrinepathogenesistherapeuticsvomiting

Identifiers

PMID26770271
PMCPMC4699282

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.